GR3026392T3 - Use of steroid antagonists for the therapy and prophylaxis of demential illnesses - Google Patents

Use of steroid antagonists for the therapy and prophylaxis of demential illnesses

Info

Publication number
GR3026392T3
GR3026392T3 GR980400589T GR980400589T GR3026392T3 GR 3026392 T3 GR3026392 T3 GR 3026392T3 GR 980400589 T GR980400589 T GR 980400589T GR 980400589 T GR980400589 T GR 980400589T GR 3026392 T3 GR3026392 T3 GR 3026392T3
Authority
GR
Greece
Prior art keywords
steroid
antagonists
receptor
prophylaxis
therapy
Prior art date
Application number
GR980400589T
Other languages
English (en)
Inventor
Rainer Denecke
Original Assignee
Altramed Holdings Ltd Denecke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altramed Holdings Ltd Denecke filed Critical Altramed Holdings Ltd Denecke
Publication of GR3026392T3 publication Critical patent/GR3026392T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR980400589T 1993-04-10 1998-03-17 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses GR3026392T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4311870A DE4311870C2 (de) 1993-04-10 1993-04-10 Verwendung eines Anti-Östrigens zur Therapie und Prophylaxe von Demenz-Erkrankungen
PCT/DE1994/000366 WO1994023708A1 (de) 1993-04-10 1994-03-30 Verwendung von steroid-antagonisten zur therapie und prophylaxe von demenz-erkrankungen

Publications (1)

Publication Number Publication Date
GR3026392T3 true GR3026392T3 (en) 1998-06-30

Family

ID=6485255

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400589T GR3026392T3 (en) 1993-04-10 1998-03-17 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses

Country Status (11)

Country Link
US (2) US6232350B1 (el)
EP (2) EP0797990A3 (el)
JP (1) JPH08508507A (el)
AT (1) ATE163543T1 (el)
AU (1) AU690110B2 (el)
CA (1) CA2160132C (el)
DE (2) DE4311870C2 (el)
DK (1) DK0692962T3 (el)
ES (1) ES2114188T3 (el)
GR (1) GR3026392T3 (el)
WO (1) WO1994023708A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1440395A (en) * 1993-12-21 1995-07-10 Eli Lilly And Company Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
US6562862B1 (en) 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
CA2208856A1 (en) * 1995-01-20 1996-07-25 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders
CA2301032C (en) * 1997-08-15 2009-01-13 Duke University A method of preventing or treating estrogen-dependent diseases and disorders
GB9824207D0 (en) * 1998-11-04 1998-12-30 Zeneca Ltd Neurological disorders
AR027878A1 (es) * 1999-11-05 2003-04-16 Wyeth Corp Metodos para identificar y utilizar compuestos inhibidores de amiloides
US7067550B2 (en) * 2000-11-03 2006-06-27 Massachusetts Institute Of Technology Treatments for neurotoxicity in Alzheimer's Disease
WO2005105063A1 (en) * 2004-05-03 2005-11-10 Universita' Degli Studi Di Firenze Pharmaceutical compositions containing serms for the treatment of alzheimer's disease
US7473687B2 (en) 2005-03-24 2009-01-06 Emory University Methods for the treatment of a traumatic central nervous system injury
PL2030622T3 (pl) 2005-03-24 2011-07-29 Univ Emory Wskazanie dawkowania progesteronu w leczeniu urazowego uszkodzenia mózgu

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046719C2 (de) * 1980-12-11 1983-02-17 Klinge Pharma GmbH, 8000 München 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
US5491173A (en) * 1982-06-25 1996-02-13 Orion-Yhtyma Oy Tri-phenyl alkene derivatives and their preparation and use
US4791099A (en) * 1984-10-29 1988-12-13 Chaovanee Aroonsakul Method of treatment for central nervous system diseases such as Alzheimer's's disease
EP0263213B1 (en) * 1986-10-09 1995-09-06 The Upjohn Company C20 Through C26 amino steroids
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
US5589500A (en) * 1992-05-01 1996-12-31 British Technology Group Limited Substituted 1,1,2-triphenylbutenes and their use in the treatment of cancer
US5264619B1 (en) * 1993-01-15 1996-05-14 Cosmos Pharm Corp Anti-androgenic cyclo and bicyclo alkenes
US5455275A (en) * 1994-05-11 1995-10-03 Eli Lilly And Company Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
IL120269A0 (en) * 1996-02-28 1997-06-10 Pfizer 1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's disease

Also Published As

Publication number Publication date
US20010018434A1 (en) 2001-08-30
EP0692962B1 (de) 1998-03-04
WO1994023708A1 (de) 1994-10-27
CA2160132A1 (en) 1994-10-27
DE4311870A1 (de) 1994-10-13
CA2160132C (en) 2002-01-15
EP0692962A1 (de) 1996-01-24
DE4311870C2 (de) 1998-07-30
EP0797990A3 (de) 1997-10-08
DE59405394D1 (de) 1998-04-09
AU690110B2 (en) 1998-04-23
ATE163543T1 (de) 1998-03-15
JPH08508507A (ja) 1996-09-10
US6232350B1 (en) 2001-05-15
AU6501494A (en) 1994-11-08
DK0692962T3 (da) 1998-09-28
ES2114188T3 (es) 1998-05-16
EP0797990A2 (de) 1997-10-01

Similar Documents

Publication Publication Date Title
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
GR3026392T3 (en) Use of steroid antagonists for the therapy and prophylaxis of demential illnesses
HK1089387A1 (en) Estrogenic compounds as antimitotic agents
ZW4488A1 (en) Steroid 5-alpha-reductase inhibitors
EP0123115A3 (en) Ascorbate interference-resistant composition, device and method for the determination of peroxidatively active substances
HK45794A (en) Silicon thin film transistor and method for producing the same
AU3128195A (en) Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone
EP0599730A3 (en) Semiconductor component and its manufacturing process.
EP0583897A3 (en) Field-effect transistor with structure for suppressing hot-electron effects, and method of fabricating the transistor
AU2883689A (en) The use of moclobemide to treat or prevent cognitive disorders
SG46182A1 (en) Superconducting field-effect transistors with inverted misfet structure and method for making the same
NO940435D0 (no) Stabil zeolitt med lav enhetscellekonstant og fremgangsmaate for fremstilling av samme
EP0365291A3 (en) Transistor amplifier for high slew rates and capative loads
NZ334786A (en) Use of a Hydrogen, Potassium-ATPase inhibitor in the treatment of nasal polyps, asthma and Widal's syndrome
AU1799888A (en) Method and device for controlling the condition of lengthy objects
DE3478899D1 (en) Improved betamethasone dipropionate cream
TW347501B (en) Memory and microcomputer
AU2761488A (en) Steroidal compounds and process for lengthening the side-chain of certain steroids
DE69923988D1 (de) Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta-estern desselben
AU1494788A (en) Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs
AU8009087A (en) Blowhole-pit preventing agent and arc-welding method using the same
AU6386894A (en) Arrangement of chair, bench, or the like, with pivotable back rest and associated neck support
ZA938744B (en) Agent and method for the immunological determination of amiodarone and its metabolites.
Hinohara Tracheostomy: Indications and Post-operative Care
Shang-Ying The Laoguanzhai and Ziba Religions During the Reign of Qianlung and their Anti-Qing Activities